celecoxib has been researched along with Diabetic Retinopathy in 7 studies
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this prospective, factorial, randomized, multicenter trial, we compared cyclo-oxygenase-2 inhibitor (celecoxib) with placebo and diode grid laser with standard Early Treatment Diabetic Retinopathy Study focal laser treatment in 86 participants with diabetic macular edema." | 9.14 | Preliminary assessment of celecoxib and microdiode pulse laser treatment of diabetic macular edema. ( Aiello, LP; Avery, R; Callanan, D; Chew, EY; Coleman, HR; Ferris, FL; Figueroa, M; Fish, G; Haller, JA; Hammel, K; Ip, M; Kim, J; Martin, D; Thompson, DJ, 2010) |
| "In this prospective, factorial, randomized, multicenter trial, we compared cyclo-oxygenase-2 inhibitor (celecoxib) with placebo and diode grid laser with standard Early Treatment Diabetic Retinopathy Study focal laser treatment in 86 participants with diabetic macular edema." | 5.14 | Preliminary assessment of celecoxib and microdiode pulse laser treatment of diabetic macular edema. ( Aiello, LP; Avery, R; Callanan, D; Chew, EY; Coleman, HR; Ferris, FL; Figueroa, M; Fish, G; Haller, JA; Hammel, K; Ip, M; Kim, J; Martin, D; Thompson, DJ, 2010) |
| "The present investigation is aimed at improving the ocular bioavailability of a poorly water soluble drug, celecoxib, to offer new options in the treatment of chronic eye diseases, such as age-related macular degeneration and diabetic retinopathy." | 3.79 | Synthesis, characterization and in vitro studies of celecoxib-loaded poly(ortho ester) nanoparticles targeted for intraocular drug delivery. ( Jablonski, MM; Palamoor, M, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Palamoor, M | 1 |
| Jablonski, MM | 1 |
| Cheruvu, NP | 2 |
| Amrite, AC | 3 |
| Kompella, UB | 3 |
| Chew, EY | 1 |
| Kim, J | 1 |
| Coleman, HR | 1 |
| Aiello, LP | 1 |
| Fish, G | 1 |
| Ip, M | 1 |
| Haller, JA | 1 |
| Figueroa, M | 1 |
| Martin, D | 1 |
| Callanan, D | 1 |
| Avery, R | 1 |
| Hammel, K | 1 |
| Thompson, DJ | 1 |
| Ferris, FL | 1 |
| Amrite, A | 1 |
| Pugazhenthi, V | 1 |
| Cheruvu, N | 1 |
| Kompella, U | 1 |
| Ayalasomayajula, SP | 2 |
| Berkowitz, BA | 1 |
| Roberts, R | 1 |
| Luan, H | 1 |
| Peysakhov, J | 1 |
| Knoerzer, DL | 1 |
| Connor, JR | 1 |
| Hohman, TC | 1 |
1 review available for celecoxib and Diabetic Retinopathy
| Article | Year |
|---|---|
Delivery of celecoxib for treating diseases of the eye: influence of pigment and diabetes.
Topics: Animals; Celecoxib; Cyclooxygenase 2 Inhibitors; Diabetic Retinopathy; Drug Delivery Systems; Humans | 2010 |
1 trial available for celecoxib and Diabetic Retinopathy
| Article | Year |
|---|---|
Preliminary assessment of celecoxib and microdiode pulse laser treatment of diabetic macular edema.
Topics: Administration, Oral; Capillary Permeability; Celecoxib; Combined Modality Therapy; Cyclooxygenase 2 | 2010 |
5 other studies available for celecoxib and Diabetic Retinopathy
| Article | Year |
|---|---|
Synthesis, characterization and in vitro studies of celecoxib-loaded poly(ortho ester) nanoparticles targeted for intraocular drug delivery.
Topics: Biological Availability; Biological Transport, Active; Celecoxib; Cell Line; Chemistry, Pharmaceutic | 2013 |
Effect of diabetes on transscleral delivery of celecoxib.
Topics: Animals; Area Under Curve; Blood Glucose; Blood-Retinal Barrier; Body Weight; Capillary Permeability | 2009 |
Inhibition of cyclooxygenase-2, but not cyclooxygenase-1, reduces prostaglandin E2 secretion from diabetic rat retinas.
Topics: Animals; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase | 2004 |
Drug intervention can correct subnormal retinal oxygenation response in experimental diabetic retinopathy.
Topics: Animals; Blood Glucose; Carbon Dioxide; Celecoxib; Cyclooxygenase Inhibitors; Diabetes Mellitus, Exp | 2005 |
Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.
Topics: Animals; Blood-Retinal Barrier; Capillary Permeability; Celecoxib; Cell Culture Techniques; Cyclooxy | 2006 |